Skip to main content
Erschienen in: World Journal of Urology 8/2017

16.12.2016 | Original Article

Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis

verfasst von: Lana Pepdjonovic, Guan Hee Tan, Sean Huang, Sarah Mann, Mark Frydenberg, Daniel Moon, Uri Hanegbi, Adam Landau, Ross Snow, Jeremy Grummet

Erschienen in: World Journal of Urology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determine the rate of hospital admissions for infection after transperineal biopsy of prostate (TPB) with single-dose cephazolin prophylaxis using a prospective database.

Method

Between April 2013 and February 2016, 577 patients undergoing TPB had 2 g of cephazolin given intravenously at induction of anaesthesia. Data collected from these patients included age, PSA, prostate volume, number of cores taken and post-operative complications.

Results

No patients were readmitted to hospital with infection post-TPB. Seven patients developed acute urinary retention, and one patient developed clinical prostatitis that was treated with oral antibiotics in the community.

Conclusion

It is safe to use single-dose cephazolin only as antibiotic prophylaxis prior to TPB, negating the need for quinolones. This study supports Australia’s current Therapeutic Guidelines recommendation for TPB prophylaxis and the existing evidence that sepsis post-TPB is a rare complication. Whether any antibiotic prophylaxis is needed at all for TPB is the subject of a future study.
Literatur
1.
Zurück zum Zitat Loeb S, Carter HB, Berndt SI et al (2011) Complications after prostate biopsy: data from SEER-medicare. J Urol 186(5):1830–1834CrossRefPubMed Loeb S, Carter HB, Berndt SI et al (2011) Complications after prostate biopsy: data from SEER-medicare. J Urol 186(5):1830–1834CrossRefPubMed
2.
Zurück zum Zitat Davis P, Paul E, Grummet J (2015) Current practice of prostate biopsy in Australia and New Zealand: a survey. Urol Ann 7(3):315–319PubMedPubMedCentral Davis P, Paul E, Grummet J (2015) Current practice of prostate biopsy in Australia and New Zealand: a survey. Urol Ann 7(3):315–319PubMedPubMedCentral
6.
Zurück zum Zitat Nam RK, Saskin R, Lee Y et al (2013) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189(1 Suppl):S12–S17 (discussion S17–S18) CrossRefPubMed Nam RK, Saskin R, Lee Y et al (2013) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189(1 Suppl):S12–S17 (discussion S17–S18) CrossRefPubMed
7.
Zurück zum Zitat Wagenlehner FM, van Oostrum E, Tenke P et al (2013) Infective complications after prostate biopsy: outcome of the global prevalence study of infections in urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 63(3):521–527CrossRefPubMed Wagenlehner FM, van Oostrum E, Tenke P et al (2013) Infective complications after prostate biopsy: outcome of the global prevalence study of infections in urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 63(3):521–527CrossRefPubMed
8.
Zurück zum Zitat Zaytoun OM, Vargo EH, Rajan R et al (2011) Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology 77(5):1035–1041CrossRefPubMed Zaytoun OM, Vargo EH, Rajan R et al (2011) Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology 77(5):1035–1041CrossRefPubMed
9.
Zurück zum Zitat Grummet JP, Weerakoon M, Huang S et al (2014) Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy? BJU Int 114(3):384–388PubMed Grummet JP, Weerakoon M, Huang S et al (2014) Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy? BJU Int 114(3):384–388PubMed
10.
Zurück zum Zitat Vyas L, Acher P, Kinsella J et al (2014) Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases. BJU Int 114(1):32–37CrossRefPubMed Vyas L, Acher P, Kinsella J et al (2014) Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases. BJU Int 114(1):32–37CrossRefPubMed
11.
Zurück zum Zitat Pepe P, Aragona F (2013) Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. Urology 81(6):1142–1146CrossRefPubMed Pepe P, Aragona F (2013) Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. Urology 81(6):1142–1146CrossRefPubMed
12.
Zurück zum Zitat Suzuki M, Kawakami S, Asano T et al (2009) Safety of transperineal 14-core systematic prostate biopsy in diabetic men. Int J Urol 16(12):930–935CrossRefPubMed Suzuki M, Kawakami S, Asano T et al (2009) Safety of transperineal 14-core systematic prostate biopsy in diabetic men. Int J Urol 16(12):930–935CrossRefPubMed
14.
Zurück zum Zitat Wolf JS Jr, Bennett CJ, Dmochowski RR et al (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179(4):1379–1390CrossRefPubMed Wolf JS Jr, Bennett CJ, Dmochowski RR et al (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179(4):1379–1390CrossRefPubMed
15.
Zurück zum Zitat Lee G, Attar K, Laniado M et al (2007) Trans-rectal ultrasound guided biopsy of the prostate: nationwide diversity in practice and training in the United Kingdom. Int Urol Nephrol 39(1):185–188CrossRefPubMed Lee G, Attar K, Laniado M et al (2007) Trans-rectal ultrasound guided biopsy of the prostate: nationwide diversity in practice and training in the United Kingdom. Int Urol Nephrol 39(1):185–188CrossRefPubMed
16.
Zurück zum Zitat Raaijmakers R, Kirkels WJ, Roobol MJ et al (2002) Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60(5):826–830CrossRefPubMed Raaijmakers R, Kirkels WJ, Roobol MJ et al (2002) Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60(5):826–830CrossRefPubMed
17.
Zurück zum Zitat Drew RJ, Turton JF, Hill RL et al (2013) Emergence of carbapenem-resistant enterobacteriaceae in a UK paediatric hospital. J Hosp Infect 84(4):300–304CrossRefPubMed Drew RJ, Turton JF, Hill RL et al (2013) Emergence of carbapenem-resistant enterobacteriaceae in a UK paediatric hospital. J Hosp Infect 84(4):300–304CrossRefPubMed
18.
Zurück zum Zitat Kotsanas D, Wijesooriya WR, Korman TM et al (2013) “Down the drain”: carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks. Med J Aust 198(5):267–269CrossRefPubMed Kotsanas D, Wijesooriya WR, Korman TM et al (2013) “Down the drain”: carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks. Med J Aust 198(5):267–269CrossRefPubMed
19.
Zurück zum Zitat Cuevas O, Oteo J, Lazaro E et al (2011) Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid. J Antimicrob Chemother 66(3):664–669CrossRefPubMed Cuevas O, Oteo J, Lazaro E et al (2011) Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid. J Antimicrob Chemother 66(3):664–669CrossRefPubMed
20.
Zurück zum Zitat Taylor S, Margolick J, Abughosh Z et al (2013) Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. BJU Int 111(6):946–953CrossRefPubMed Taylor S, Margolick J, Abughosh Z et al (2013) Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. BJU Int 111(6):946–953CrossRefPubMed
21.
Zurück zum Zitat Leahy OR, O’Reilly M, Dyer DR et al (2014) Transrectal ultrasound-guided biopsy sepsis and the rise in carbapenem antibiotic use. ANZ J Surg. doi:10.1111/ans.12933 PubMed Leahy OR, O’Reilly M, Dyer DR et al (2014) Transrectal ultrasound-guided biopsy sepsis and the rise in carbapenem antibiotic use. ANZ J Surg. doi:10.​1111/​ans.​12933 PubMed
22.
Zurück zum Zitat Borer A, Gilad J, Sikuler E et al (1999) Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy. J Infect 38(2):128–129CrossRefPubMed Borer A, Gilad J, Sikuler E et al (1999) Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy. J Infect 38(2):128–129CrossRefPubMed
23.
Zurück zum Zitat Brewster SF, Rooney N, Kabala J et al (1993) Fatal anaerobic infection following transrectal biopsy of a rare prostatic tumor. Br J Urol 72(6):977–978CrossRefPubMed Brewster SF, Rooney N, Kabala J et al (1993) Fatal anaerobic infection following transrectal biopsy of a rare prostatic tumor. Br J Urol 72(6):977–978CrossRefPubMed
Metadaten
Titel
Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis
verfasst von
Lana Pepdjonovic
Guan Hee Tan
Sean Huang
Sarah Mann
Mark Frydenberg
Daniel Moon
Uri Hanegbi
Adam Landau
Ross Snow
Jeremy Grummet
Publikationsdatum
16.12.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 8/2017
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-016-1985-1

Weitere Artikel der Ausgabe 8/2017

World Journal of Urology 8/2017 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.